Alignment Healthcare (US.ALHC)
Capital Allocation Audit · Period: 2019 – 2026
Key Metrics
US.ALHC · YoY: 2026 H1 vs 2025 H1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 84.3% | ↑ |
| ROE | 18.1% | ↑ |
| Cash Conversion | 232.1% | ↓ |
| D/E Ratio | 1.25 | ↑ |
| Gross Margin | 12.7% | → |
US.ALHC (Alignment Healthcare) | YoY: 2026 H1 vs 2025 H1 Metric Value YoY ---------------------------- FCF Conversion 84.3% ↑ ROE 18.1% ↑ Cash Conversion 232.1% ↓ D/E Ratio 1.25 ↑ Gross Margin 12.7% →
Key Metrics
US.ALHC (Alignment Healthcare) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY----------------------------FCF Conversion 84.3% ↑ROE 18.1% ↑Cash Conversion 232.1% ↓D/E Ratio 1.25 ↑Gross Margin 12.7% →Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies